İBG is happy to announce that it has been awarded grant support from the Horizon Europe Marie Curie Actions Staff Exchanges program of the European Commission.
This project, named CHIRON, is funded with 1.53 million € for 4 years. Two of IBG’s Research Group Leaders, Dr. Gerhard Wingender and Dr. Duygu Sag, are involved in this project, with Dr. Wingender being the project coordinator and Dr. Sag as the partner from Dokuz Eylul University (DEU). They are joined by a large international research team from six research laboratories and three companies from six other countries (Greece, Hungary, Ireland, France, Sweden, and Switzerland). Together with their international colleagues, Dr. Sag and Dr. Wingender will investigate how established tumours can evade the immune system. In particular, the team will elucidate the role particular death receptors play in this process and how this can be modulated to improve the immune response against cancer.